Serum Anti-Mullerian Hormone, Serum Follicle Stimulating Hormone and Serum Estradiol in the Prediction of Ovarian Reserve: A Comparative Study
暂无分享,去创建一个
[1] Urvashi B Singh,et al. Anti-Mullerian Hormone: A New Marker of Ovarian Function , 2014, The Journal of Obstetrics and Gynecology of India.
[2] E. Bosch,et al. Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients , 2011, Reproductive biology and endocrinology : RB&E.
[3] F. Broekmans,et al. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. , 2011, Human reproduction update.
[4] W. Ledger. Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology. , 2010, The Journal of clinical endocrinology and metabolism.
[5] A. Moawad,et al. Early follicular anti-mullerian hormone as a predictor of ovarian response during ICSI cycles , 2010 .
[6] A. Volpe,et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). , 2010, Human reproduction update.
[7] J. Holte,et al. High basal LH levels in combination with low basal FSH levels are associated with high success rates at assisted reproduction. , 2009, Human reproduction.
[8] F. Broekmans,et al. Relationship of serum antimüllerian hormone concentration to age at menopause. , 2008, The Journal of clinical endocrinology and metabolism.
[9] S. Nelson,et al. Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy. , 2007, Human reproduction.
[10] J. Boivin,et al. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. , 2007, Human reproduction.
[11] F. Broekmans,et al. Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. , 2006, The Journal of clinical endocrinology and metabolism.
[12] K. Oktay,et al. Measuring the impact of chemotherapy on fertility in women with breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] T. Kutlu,et al. Early follicular antimüllerian hormone as an indicator of ovarian reserve. , 2006, Fertility and sterility.
[14] P. Serhal,et al. Antral follicle count, anti‐mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? , 2005, BJOG : an international journal of obstetrics and gynaecology.
[15] L. Gianaroli,et al. Fertility and ageing. , 2005, Human reproduction update.
[16] R. Fanchin,et al. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. , 2003, Human reproduction.
[17] J. Toner. Ovarian reserve, female age and the chance for successful pregnancy. , 2003, Minerva ginecologica.
[18] F. Broekmans,et al. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. , 2002, Human reproduction.
[19] M. Perloe,et al. Strategies for ascertaining ovarian reserve among women suspected of subfertility. , 2000, International journal of fertility and women's medicine.
[20] Z. Rosenwaks,et al. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. , 1995, Fertility and sterility.
[21] N. Fournet,et al. Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age. , 1992, Fertility and sterility.